Showing results (81-90 of 126) with videos related to
Sort By:
Pageof 13
Cancer Chemotherapy and Pharmacology|May 27, 2018
Pharmacodynamic study using FLT PET/CT in advanced solid malignancies treated with a sequential combination of X-82 and docetaxelMatthew Scarpelli, Murtuza Rampurwala, Jens Eickhoff, et al.Investigational New Drugs|November 20, 2015
A phase II trial of ganetespib, a heat shock protein 90 Hsp90) inhibitor, in patients with docetaxel-pretreated metastatic castrate-resistant prostate cancer (CRPC)-a prostate cancer clinical trials consortium (PCCTC) studyManish K Thakur, Lance K Heilbrun, Shijie Sheng, et al.American Journal of Translational Research|September 1, 2012
ImmunoPET and near-infrared fluorescence imaging of CD105 expression using a monoclonal antibody dual-labeled with (89)Zr and IRDye 800CWYin Zhang, Hao Hong, Gregory W Severin, et al.Investigational New Drugs|October 28, 2003
Phase II trial of perillyl alcohol (NSC 641066) administered daily in patients with metastatic androgen independent prostate cancerGlenn Liu, Kurt Oettel, Howard Bailey, et al.Investigational New Drugs|January 6, 2015
Phase 1/2 study of orteronel (TAK-700), an investigational 17,20-lyase inhibitor, with docetaxel-prednisone in metastatic castration-resistant prostate cancerDaniel P Petrylak, Jitendra G Gandhi, William R Clark, et al.Cancer Chemotherapy and Pharmacology|April 14, 2010
Phase I dose escalation study of MK-0457, a novel Aurora kinase inhibitor, in adult patients with advanced solid tumorsAnne M Traynor, Maureen Hewitt, Glenn Liu, et al.Cancer Chemotherapy and Pharmacology|January 22, 2016
A pharmacodynamically guided dose selection of PF-00337210 in a phase I study in patients with advanced solid tumorsJustine Yang Bruce, Patricia M LoRusso, Priscila H Goncalves, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2017
Quantitative Assessment of Early [18F]Sodium Fluoride Positron Emission Tomography/Computed Tomography Response to Treatment in Men With Metastatic Prostate Cancer to BoneStephanie A Harmon, Timothy Perk, Christie Lin, et al.Cancer Chemotherapy and Pharmacology|January 14, 2014
A phase I pharmacodynamic trial of sequential sunitinib with bevacizumab in patients with renal cell carcinoma and other advanced solid malignanciesJustine Yang Bruce, Jill M Kolesar, Hans Hammers, et al.Clinical Genitourinary Cancer|February 9, 2013
Five-year survival in patients with cytokine-refractory metastatic renal cell carcinoma treated with axitinibBrian I Rini, Thibault de La Motte Rouge, Andrea L Harzstark, et al.Pageof 13